ProQR Therapeutics (PRQR) Intangibles (2013 - 2018)
ProQR Therapeutics (PRQR) posted Intangibles of -$218006.7 for Q4 2018, down 480692.87% sequentially from $45.36 in Q3 2018, and down 574.75% YoY from $45919.9 in Q4 2017.
ProQR Therapeutics (PRQR) Intangibles (2013 - 2018) Analysis & Trends
ProQR Therapeutics has reported Intangibles for 6 years, with the latest figure at -$218006.7 in Q4 2018.
- Quarterly Intangibles fell 574.75% year-over-year to -$218006.7 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was -$218006.7 (down 574.75% YoY) and the FY2018 annual result came in at -$218006.7, down 574.75% from the prior year.
- Intangibles fell to -$218006.7 in Q4 2018 per PRQR's latest filing, from $45.36 in the prior quarter.
- Over five years, Intangibles peaked at $203722.9 in Q4 2014 and troughed at -$218006.7 in Q4 2018.
- A 5-year average of $50328.7 and a median of $46544.3 in 2018 frame the typical range for Intangibles.
- The sharpest annual moves came in 2014 and 2018: Intangibles surged 283.79% in 2014, then tumbled 574.75% in 2018.
- Over 5 years, Intangibles stood at $203722.9 in 2014, then decreased by 24.14% to $154552.5 in 2015, then slumped by 37.12% to $97175.2 in 2016, then plunged by 52.75% to $45919.9 in 2017, then sank by 574.75% to -$218006.7 in 2018.
- According to Business Quant data, Intangibles over the past three periods registered -$218006.7, $45.36, and $46544.3 for Q4 2018, Q3 2018, and Q2 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 266.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 63.28 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 60.96 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 93.49 Mn |
| 10 | ProQR Therapeutics | 206.80 Mn | 111.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -218,006.72 |
| Sep 30, 2018 | 45.36 |
| Jun 30, 2018 | 46,544.33 |
| Mar 31, 2018 | 47.91 |
| Dec 31, 2017 | 45,919.87 |
| Dec 31, 2016 | 97,175.18 |
| Sep 30, 2016 | 114.97 |
| Dec 31, 2015 | 154,552.54 |
| Mar 31, 2015 | 171,734.54 |
| Dec 31, 2014 | 203,722.86 |
| Sep 30, 2014 | 51,764.37 |
| Dec 31, 2013 | 53,082.49 |